Study Examines Retatrutide's Impact on Insulin Metrics in Type 2 Diabetes | Retatrutide News

A clinical trial is evaluating retatrutide's effect on insulin metrics in type 2 diabetes over 28 weeks. The study compares retatrutide with placebo to ...
Clinical Trials · October 22, 2026